Give me class,mechanism of action, uses and side effects and contra indications of each drug, for my mbbs practical viva exam of Medicine
| Class | Dihydropyridine Calcium Channel Blocker (CCB) |
| Mechanism | Blocks L-type voltage-gated Ca²⁺ channels in vascular smooth muscle → vasodilation → reduced peripheral resistance and BP |
| Uses | Hypertension, Stable angina, Vasospastic (Prinzmetal) angina |
| Side Effects | Peripheral edema (ankle), flushing, headache, reflex tachycardia, gingival hyperplasia |
| Contraindications | Cardiogenic shock, Severe aortic stenosis, Hypersensitivity |
| Class | Non-selective COX inhibitor / Antiplatelet / NSAID |
| Mechanism | Irreversibly inhibits COX-1 & COX-2 → ↓ TXA₂ (antiplatelet at low dose); ↓ PGs (analgesic/antipyretic at higher dose) |
| Uses | Antiplatelet: ACS, MI, stroke prevention; Analgesic, Antipyretic, Anti-inflammatory; Kawasaki disease |
| Side Effects | GI ulceration/bleeding, tinnitus (toxicity), Reye's syndrome (children), bronchospasm, prolonged bleeding time |
| Contraindications | Peptic ulcer, Children with viral illness, Bleeding disorders, Aspirin-sensitive asthma, 3rd trimester pregnancy |
| Class | Cardioselective β1-blocker (without ISA) |
| Mechanism | Selectively blocks β1 adrenergic receptors → ↓ HR, ↓ contractility, ↓ BP, ↓ renin release |
| Uses | Hypertension, Angina, Post-MI, Arrhythmias (SVT), Hyperthyroidism (symptomatic relief) |
| Side Effects | Bradycardia, fatigue, cold extremities, sexual dysfunction, masking of hypoglycemia |
| Contraindications | Bronchial asthma, AV block (2nd/3rd degree), Cardiogenic shock, Sick sinus syndrome, COPD (relative) |
| Class | HMG-CoA reductase inhibitor (Statin) |
| Mechanism | Inhibits HMG-CoA reductase → ↓ cholesterol synthesis in liver → ↑ LDL receptors → ↓ LDL, ↓ TG, ↑ HDL |
| Uses | Hypercholesterolemia, Prevention of cardiovascular events (MI, stroke), Dyslipidemia |
| Side Effects | Myopathy/rhabdomyolysis (↑ CPK), hepatotoxicity (↑ LFTs), GI upset, headache |
| Contraindications | Active liver disease, Pregnancy & lactation, Myopathy, Concurrent use of strong CYP3A4 inhibitors |
| Class | 1st generation H1 antihistamine |
| Mechanism | Competitive antagonist at H1 histamine receptors; crosses BBB → sedation; also has anticholinergic effects |
| Uses | Allergic rhinitis, Urticaria, Drug/food allergy, Common cold (symptomatic), Motion sickness (CPM) |
| Side Effects | Sedation, dry mouth, urinary retention, blurred vision, constipation, paradoxical excitation in children |
| Contraindications | Glaucoma (narrow-angle), BPH, Pyloric stenosis, Operating machinery, Neonates |
| Class | Macrolide antibiotic (Azalide subclass) |
| Mechanism | Binds 50S ribosomal subunit → inhibits translocation → bacteriostatic (bactericidal at high doses) |
| Uses | Community-acquired pneumonia, Atypical pneumonia (Mycoplasma, Chlamydia, Legionella), STIs (Chlamydia, gonorrhea), Typhoid, MAC prophylaxis in HIV |
| Side Effects | GI upset (N/V/D), QT prolongation, cholestatic jaundice, hearing loss (high dose/prolonged) |
| Contraindications | Hepatic failure, QT prolongation/arrhythmia history, Hypersensitivity to macrolides |
| Class | Benzodiazepine (short-acting) |
| Mechanism | Enhances GABA-A receptor activity → ↑ Cl⁻ influx → CNS depression |
| Uses | Anxiety disorders (GAD, Panic disorder), Short-term insomnia, Alcohol withdrawal (adjunct) |
| Side Effects | Sedation, dependence/addiction, tolerance, anterograde amnesia, respiratory depression |
| Contraindications | Myasthenia gravis, Sleep apnea, Acute narrow-angle glaucoma, Pregnancy (1st trimester), Severe hepatic disease |
| Class | Anticonvulsant / Mood stabilizer (Iminostilbene derivative) |
| Mechanism | Blocks voltage-gated Na⁺ channels (use-dependent) → stabilizes neuronal membranes → reduces repetitive firing |
| Uses | Epilepsy (partial/tonic-clonic seizures — drug of choice), Trigeminal neuralgia (DOC), Bipolar disorder, Diabetic neuropathy |
| Side Effects | Diplopia, ataxia, drowsiness, Stevens-Johnson syndrome (HLA-B*1502 risk), agranulocytosis, aplastic anemia, SIADH, teratogenicity |
| Contraindications | AV block, Bone marrow depression, Porphyria, MAO inhibitor use, Absence/myoclonic seizures |
| Class | Non-selective β + α1 blocker (3rd generation beta-blocker) |
| Mechanism | Blocks β1, β2, and α1 receptors → ↓ HR, ↓ BP, vasodilation (α1 block); antioxidant properties |
| Uses | Heart failure (↓ mortality — evidence-based), Hypertension, Post-MI LV dysfunction, Angina |
| Side Effects | Dizziness, bradycardia, hypotension (especially 1st dose), fatigue, fluid retention |
| Contraindications | Decompensated heart failure, Severe bradycardia, AV block, Asthma/COPD, Cardiogenic shock |
| Class | 3rd generation Cephalosporin (oral) |
| Mechanism | Binds Penicillin-Binding Proteins (PBPs) → inhibits cell wall synthesis → bactericidal |
| Uses | UTI, Typhoid fever, Gonorrhea, Upper/lower respiratory tract infections, Otitis media |
| Side Effects | GI upset, diarrhea, hypersensitivity (rash, urticaria), pseudomembranous colitis (rare), ↑ LFTs |
| Contraindications | Penicillin allergy (cross-reactivity ~1–2%), Severe renal impairment (dose adjustment needed) |
| Class | 2nd generation H1 antihistamine (R-enantiomer of cetirizine) |
| Mechanism | Selective peripheral H1 antagonist; minimal CNS penetration → non-sedating |
| Uses | Allergic rhinitis, Chronic urticaria, Atopic dermatitis, Allergic conjunctivitis |
| Side Effects | Mild sedation, dry mouth, headache, fatigue (minimal compared to 1st gen) |
| Contraindications | Severe renal failure (CrCl <10 mL/min), Hypersensitivity, Children <2 years |
| Class | 2nd generation Fluoroquinolone antibiotic |
| Mechanism | Inhibits DNA gyrase (topoisomerase II) and topoisomerase IV → prevents DNA replication → bactericidal |
| Uses | UTI, Typhoid fever, GI infections (traveller's diarrhea, Salmonella), RTIs, Anthrax, Bone/joint infections, Gonorrhea |
| Side Effects | GI upset, tendinitis/tendon rupture (Achilles), QT prolongation, CNS effects (seizures, dizziness), photosensitivity, cartilage damage in children |
| Contraindications | Children & growing adolescents (cartilage damage), Pregnancy & lactation, Epilepsy (relative), Concurrent antacids (↓ absorption) |
| Class | P2Y12 ADP receptor antagonist / Antiplatelet (Thienopyridine) |
| Mechanism | Irreversibly blocks P2Y12 ADP receptors on platelets → ↓ ADP-induced platelet aggregation → ↓ thrombus formation |
| Uses | ACS (NSTEMI, STEMI), Post-PCI/stent, Stroke/TIA prevention, Peripheral arterial disease (often with aspirin — DAPT) |
| Side Effects | Bleeding, TTP (rare but life-threatening), GI upset, rash, neutropenia |
| Contraindications | Active bleeding, Severe hepatic impairment, Hypersensitivity; Caution: CYP2C19 poor metabolizers (reduced efficacy), PPI use (omeprazole — reduces effect) |
| Class | Xanthine derivative (Bronchodilator) |
| Mechanism | Inhibits phosphodiesterase → ↑ cAMP → bronchial smooth muscle relaxation; also adenosine receptor antagonism |
| Uses | Bronchial asthma, COPD, Bronchospasm |
| Side Effects | Nausea, vomiting, palpitations, tachycardia, seizures (toxicity), insomnia, headache |
| Contraindications | Peptic ulcer, Seizure disorders, Cardiac arrhythmias, Hyperthyroidism; Narrow therapeutic index — monitor levels |
| Class | Synthetic corticosteroid (glucocorticoid) |
| Mechanism | Binds glucocorticoid receptors → inhibits NF-κB → ↓ cytokines, ↓ prostaglandins, ↓ inflammatory cells; stabilizes cell membranes |
| Uses | Cerebral edema, Meningitis, Anaphylaxis, Severe asthma/COPD exacerbation, Adrenal insufficiency, Anti-emetic (chemo), COVID-19 (severe), Croup |
| Side Effects | Cushing's syndrome, hyperglycemia, osteoporosis, immunosuppression, peptic ulcer, psychiatric effects, growth retardation |
| Contraindications | Active systemic infections (without cover), Live vaccines, Peptic ulcer (relative), Psychosis (relative); never stop abruptly (adrenal suppression) |
| Class | Non-selective NSAID (Acetic acid derivative) |
| Mechanism | Inhibits COX-1 & COX-2 → ↓ prostaglandin synthesis → analgesic, anti-inflammatory, antipyretic |
| Uses | Pain (dysmenorrhea, dental, postoperative), Osteoarthritis/RA, Renal colic (IM), Gout (acute) |
| Side Effects | GI ulceration/bleeding, hepatotoxicity (↑ LFTs — unique to diclofenac), renal impairment, fluid retention, cardiovascular risk |
| Contraindications | Peptic ulcer, Renal/hepatic failure, Aspirin-sensitive asthma, Pregnancy (3rd trimester), Post-CABG |
| Class | Anticholinergic / Antispasmodic |
| Mechanism | Blocks muscarinic (M) receptors on smooth muscle of GI tract → reduces intestinal motility and spasm; direct smooth muscle relaxation |
| Uses | IBS (irritable bowel syndrome), Biliary/renal/intestinal colic, Dysmenorrhea |
| Side Effects | Dry mouth, blurred vision, urinary retention, constipation, tachycardia, CNS effects |
| Contraindications | Glaucoma, BPH, Myasthenia gravis, Achalasia, Infants <6 months (respiratory distress risk) |
| Class | Cardiac glycoside |
| Mechanism | Inhibits Na⁺/K⁺-ATPase → ↑ intracellular Na⁺ → ↑ intracellular Ca²⁺ (via Na⁺/Ca²⁺ exchanger) → positive inotropy; vagomimetic effect → ↓ AV conduction (negative chronotropy) |
| Uses | Heart failure (systolic), Atrial fibrillation (rate control), Atrial flutter |
| Side Effects | Narrow therapeutic index: GI (N/V, anorexia), visual disturbances (yellow-green vision, halos), arrhythmias (bigeminy, VT), bradycardia. Toxicity worsened by hypokalemia, hypomagnesemia, hypercalcemia |
| Contraindications | Hypertrophic obstructive cardiomyopathy, WPW syndrome, AV block (2nd/3rd degree), Ventricular fibrillation, Hypokalemia (predisposes to toxicity) |
| Class | Non-dihydropyridine Calcium Channel Blocker (Benzothiazepine) |
| Mechanism | Blocks L-type Ca²⁺ channels in cardiac and vascular smooth muscle → ↓ HR (SA node), ↓ AV conduction, vasodilation |
| Uses | Angina (stable, vasospastic), Hypertension, SVT/AF rate control, Hypertrophic cardiomyopathy |
| Side Effects | Bradycardia, AV block, constipation, edema, flushing, hepatotoxicity (rare) |
| Contraindications | Severe bradycardia, AV block (2nd/3rd degree), Sick sinus syndrome, Cardiogenic shock, WPW with AF, Concurrent β-blocker use (↑ bradycardia risk) |
| Class | Dopamine D2 receptor antagonist / Prokinetic antiemetic |
| Mechanism | Blocks peripheral D2 receptors in GI tract → ↑ LES pressure, ↑ gastric emptying, ↑ peristalsis; acts at chemoreceptor trigger zone (CTZ) — does NOT cross BBB (minimal CNS effects) |
| Uses | Nausea & vomiting, GERD, Gastroparesis, Hiccups |
| Side Effects | Hyperprolactinemia (galactorrhea, gynecomastia, amenorrhea), QT prolongation, minimal extrapyramidal effects (vs. metoclopramide) |
| Contraindications | GI obstruction/perforation, Prolactinoma, QT prolongation, Severe hepatic impairment, Concurrent CYP3A4 inhibitors |
| Class | ACE Inhibitor (Angiotensin Converting Enzyme Inhibitor) |
| Mechanism | Inhibits ACE → ↓ conversion of Angiotensin I → Angiotensin II → ↓ vasoconstriction, ↓ aldosterone → ↓ BP; also ↑ bradykinin |
| Uses | Hypertension, Heart failure (↓ mortality), Post-MI, Diabetic nephropathy (renoprotective), LV dysfunction |
| Side Effects | Dry persistent cough (bradykinin ↑), hyperkalemia, first-dose hypotension, angioedema, renal impairment |
| Contraindications | Bilateral renal artery stenosis, Pregnancy (absolutely contraindicated — fetotoxic), Hyperkalemia, Angioedema history, Concurrent ARB or aliskiren (in DM/renal disease) |
| Class | Anticonvulsant (Hydantoin derivative) |
| Mechanism | Blocks voltage-gated Na⁺ channels (use-dependent) → stabilizes neuronal membranes → ↓ repetitive neuronal firing; also ↓ Ca²⁺ influx |
| Uses | Epilepsy (partial & tonic-clonic seizures), Status epilepticus (IV), Trigeminal neuralgia, Digitalis-induced arrhythmias |
| Side Effects | Gingival hyperplasia (characteristic), hirsutism, coarse facies, acne, ataxia, nystagmus, diplopia, megaloblastic anemia (folate deficiency), teratogenicity (fetal hydantoin syndrome), zero-order kinetics (toxic accumulation), SJS |
| Contraindications | Absence/myoclonic/atonic seizures, Bradycardia, AV block, Pregnancy (relatively), Porphyria |
| Class | Loop diuretic |
| Mechanism | Inhibits Na⁺/K⁺/2Cl⁻ cotransporter (NKCC2) in thick ascending limb of Loop of Henle → ↑ excretion of Na⁺, K⁺, Cl⁻, water; also venodilation (↓ preload) |
| Uses | Pulmonary edema (emergency — IV), Heart failure, Hypertension, Ascites (cirrhosis), Nephrotic syndrome, Hypercalcemia, Hypertensive crisis |
| Side Effects | Hypokalemia, hyponatremia, dehydration, hypotension, ototoxicity (high dose IV), hyperuricemia, hyperglycemia, hypomagnesemia |
| Contraindications | Anuria, Hepatic coma, Hypokalemia/hypovolemia (relative), Allergy to sulfonamides |
| Class | Tricyclic Antidepressant (TCA) |
| Mechanism | Inhibits reuptake of norepinephrine and serotonin (5-HT) at nerve terminals → ↑ monoamine levels; also blocks muscarinic, histaminergic, and α1 receptors |
| Uses | Depression, Enuresis (bed-wetting in children — DOC), Panic disorder, Chronic pain (neuropathic), OCD |
| Side Effects | Anticholinergic (dry mouth, constipation, urinary retention, blurred vision), sedation, postural hypotension, cardiac arrhythmias (QT prolongation), weight gain, fatal in overdose (3Cs: Convulsions, Coma, Cardiac arrhythmia) |
| Contraindications | MAO inhibitor use (serotonin syndrome risk), Recent MI, Heart block, BPH, Glaucoma, Suicidal patients |
| Class | Organic nitrate / Vasodilator |
| Mechanism | Converted to NO → activates guanylyl cyclase → ↑ cGMP → smooth muscle relaxation → venodilation (↓ preload) > arterial dilation (↓ afterload) → ↓ myocardial O₂ demand |
| Uses | Angina (prophylaxis & treatment), Heart failure (with hydralazine), Acute MI, Esophageal spasm |
| Side Effects | Headache (most common), flushing, hypotension, reflex tachycardia, tolerance (nitrate-free interval needed), methemoglobinemia (rare) |
| Contraindications | Concurrent PDE-5 inhibitors (sildenafil — severe hypotension), Hypotension, Hypovolemia, Raised ICP, Severe aortic stenosis |
| Class | Angiotensin II Receptor Blocker (ARB / Sartans) |
| Mechanism | Selectively blocks AT1 receptors → ↓ vasoconstriction, ↓ aldosterone, ↓ sympathetic activation; uricosuric effect (unique to losartan) |
| Uses | Hypertension, Heart failure, Diabetic nephropathy (DOC in type 2 DM with proteinuria), Post-MI, Stroke prevention in HTN with LVH |
| Side Effects | Hyperkalemia, dizziness, renal impairment; No cough (unlike ACE inhibitors — because no bradykinin accumulation) |
| Contraindications | Pregnancy (absolutely contraindicated), Bilateral renal artery stenosis, Hyperkalemia, Concurrent ACE inhibitor (in DM/renal disease) |
| Class | Biguanide / Oral antidiabetic (first-line in T2DM) |
| Mechanism | Activates AMPK → ↓ hepatic gluconeogenesis (primary), ↑ peripheral glucose uptake, ↑ insulin sensitivity; does NOT stimulate insulin secretion → no hypoglycemia |
| Uses | Type 2 Diabetes Mellitus (drug of choice), PCOS, Prediabetes, Metabolic syndrome |
| Side Effects | GI upset (N/V/D — most common, take with food), lactic acidosis (rare but serious), vitamin B12 deficiency (long-term), metallic taste; No hypoglycemia, No weight gain |
| Contraindications | Renal failure (eGFR <30, lactic acidosis risk), Hepatic failure, IV contrast administration (hold 48h), Alcoholism, Cardiac/respiratory failure, Pregnancy |
| Class | Cardioselective β1-blocker |
| Mechanism | Selectively blocks β1 adrenergic receptors → ↓ HR, ↓ contractility, ↓ BP, ↓ renin; higher selectivity for β1 than atenolol |
| Uses | Hypertension, Angina, Heart failure (↓ mortality — evidence-based), MI, Arrhythmias, Hyperthyroidism |
| Side Effects | Bradycardia, fatigue, cold extremities, depression, sexual dysfunction, masking of hypoglycemia |
| Contraindications | Asthma/COPD (relative), AV block (2nd/3rd degree), Cardiogenic shock, Sick sinus syndrome |
| Class | Dihydropyridine Calcium Channel Blocker |
| Mechanism | Blocks L-type Ca²⁺ channels predominantly in vascular smooth muscle → vasodilation → ↓ BP; minimal cardiac effect |
| Uses | Hypertension, Angina (stable, Prinzmetal/vasospastic), Raynaud's phenomenon, Preterm labor (tocolytic), Achalasia |
| Side Effects | Reflex tachycardia, flushing, headache, ankle edema, gingival hyperplasia; Short-acting form avoided in ACS (reflex tachycardia) |
| Contraindications | Cardiogenic shock, ACS (short-acting), Severe aortic stenosis, Pregnancy (1st trimester) |
| Class | Proton Pump Inhibitor (PPI) |
| Mechanism | Prodrug → activated in acidic environment → irreversibly binds H⁺/K⁺-ATPase (proton pump) on parietal cells → ↓ gastric acid secretion |
| Uses | Peptic ulcer disease, GERD/GORD, H. pylori eradication (triple/quadruple therapy), Zollinger-Ellison syndrome, NSAID-induced gastropathy, Stress ulcer prophylaxis |
| Side Effects | Headache, GI upset, hypomagnesemia (long-term), ↓ vitamin B12 & Ca²⁺ absorption, C. difficile risk, osteoporosis (long-term), ↓ clopidogrel efficacy (CYP2C19 competition) |
| Contraindications | Concurrent clopidogrel use (preferred: pantoprazole/rabeprazole), Hypersensitivity; avoid long-term without indication |
| Class | Electrolyte replacement solution |
| Mechanism | Glucose-coupled Na⁺ cotransport (SGLT1) in enterocytes remains functional in diarrhea → facilitates Na⁺ and water absorption despite secretory state |
| Uses | Dehydration due to acute diarrhea/gastroenteritis (cholera, rotavirus), Vomiting, Heat exhaustion |
| Side Effects | Hypernatremia (if over-concentrated), nausea if taken too fast; generally very safe |
| Contraindications | Severe dehydration/shock (IV fluids preferred), Ileus, Persistent vomiting, Glucose-galactose malabsorption (rare) |
| Class | Analgesic / Antipyretic (Para-aminophenol derivative) |
| Mechanism | Inhibits COX-3 (CNS-specific) → ↓ prostaglandin synthesis centrally; also acts on endocannabinoid system; no significant peripheral anti-inflammatory effect |
| Uses | Mild-moderate pain, Fever, Osteoarthritis, Preferred in pregnancy, Preferred over aspirin in children |
| Side Effects | Hepatotoxicity (overdose — NAPQI accumulation depletes glutathione → liver necrosis); generally very safe at therapeutic doses |
| Contraindications | Severe hepatic impairment, Alcoholism; Antidote: N-acetylcysteine (NAC) |
| Class | Anticonvulsant / Mood stabilizer / Antimigraine |
| Mechanism | Blocks voltage-gated Na⁺ channels + ↑ GABA levels (inhibits GABA transaminase + glutamate decarboxylase) + blocks T-type Ca²⁺ channels |
| Uses | Broad-spectrum anticonvulsant — all seizure types (absence, tonic-clonic, myoclonic, partial); Bipolar disorder; Migraine prophylaxis |
| Side Effects | GI upset, weight gain, alopecia (hair loss), tremor, hepatotoxicity (especially <2 years), teratogenicity (neural tube defects — spina bifida), thrombocytopenia, PCOS-like syndrome |
| Contraindications | Pregnancy (neural tube defects — strongest contraindication), Hepatic disease, Mitochondrial disorders, Urea cycle disorders |
| Class | Probiotic (biological preparation with live microorganisms) |
| Mechanism | Replenishes normal gut flora → competitive exclusion of pathogenic bacteria, ↓ gut pH (lactic acid), ↑ mucosal immunity, ↓ intestinal permeability |
| Uses | Antibiotic-associated diarrhea, Acute gastroenteritis, IBS, Restoration of gut flora post-antibiotic therapy |
| Side Effects | Mild bloating, flatulence; generally very safe; rarely bacteremia in immunocompromised |
| Contraindications | Severely immunocompromised patients (HIV, post-transplant — risk of bacteremia/fungemia), Short bowel syndrome (relative) |
| Class | Angiotensin II Receptor Blocker (ARB) — longest half-life of all ARBs (~24h) |
| Mechanism | Selectively blocks AT1 receptors → ↓ vasoconstriction, ↓ aldosterone; also partial PPAR-γ agonist (↑ insulin sensitivity — metabolic benefit) |
| Uses | Hypertension, Cardiovascular risk reduction (ONTARGET trial), Diabetic nephropathy, Heart failure (ACE-intolerant patients) |
| Side Effects | Hyperkalemia, dizziness, renal impairment, hypotension; No cough |
| Contraindications | Pregnancy (absolutely contraindicated), Bilateral renal artery stenosis, Hyperkalemia, Cholestatic jaundice/biliary obstruction (hepatic excretion) |
| Drug | Remember This |
|---|---|
| Digoxin | Narrow TI; hypokalemia → toxicity; yellow vision |
| Phenytoin (Eptoin) | Gingival hyperplasia, zero-order kinetics |
| Carbamazepine | DOC trigeminal neuralgia; SJS; SIADH |
| Metformin | No hypoglycemia; lactic acidosis; hold before contrast |
| Furosemide | Loop diuretic; ototoxicity; hypokalemia |
| ACE inhibitors | Cough (bradykinin); no cough with ARBs |
| Clopidogrel | Irreversible P2Y12 block; TTP rare; omeprazole interaction |
| Sodium Valproate | Broad-spectrum AED; teratogenic (NTDs); hepatotoxic |
| Imipramine | TCA; DOC enuresis; 3Cs in overdose |
| Nitrates + PDE5i | Severe hypotension — absolute contraindication |
| Paracetamol overdose | NAC is antidote |
| Atenolol/Metoprolol | β1 selective; avoid in asthma |
| Carvedilol | β1 + β2 + α1 blocker; heart failure mortality ↓ |
| Amlodipine | Ankle edema; gingival hyperplasia |
| Domperidone | No extrapyramidal effects (doesn't cross BBB) |